ArticleArchives of osteoporosis2021

Cost-effectiveness of zoledronic acid compared with sequential denosumab/alendronate for older osteoporotic women in Japan.

Takahiro Mori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.